NCT03903081

The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single & Multiple Ascending Dose Study to Access the Tolerability and Pharmacokinetics of HEC110114 Tablets in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 93 (actual)
• Sponsor: Sunshine Lake Pharma Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Single \& Multiple Ascending Dose Study to Access the Tolerability and Pharmacokinetics of HEC110114 Tablets in Healthy Adult Subjects

Conditions

• Chronic Hepatitis C

Interventions

Type	Name	Description
DRUG	HEC110114 tablet	administered orally once daily
DRUG	Placebo Oral Tablet	Placebo will be administered orally at a dose and frequency matched to HEC110114

Timeline

• Start date: 2019-03-06
• Primary completion: 2019-10-29
• Completion: 2019-10-29
• First posted: 2019-04-04
• Last updated: 2020-03-18

Locations

1 site across 1 country: China